EX-4.2



 Exhibit 4.2 

ZENDESK, INC. 
 THIRD
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 
 SEPTEMBER 5, 2012 







 TABLE OF CONTENTS 

 

									
	 1.
	 	Definitions	  	 	1	  
			
	 2.
	 	 Registration Rights
	  	 	5	  
		 	 2.1
	  	Demand Registration	  	 	5	  
		 	 2.2
	  	Company Registration	  	 	6	  
		 	 2.3
	  	Underwriting Requirements	  	 	7	  
		 	 2.4
	  	Obligations of the Company	  	 	8	  
		 	 2.5
	  	Furnish Information	  	 	10	  
		 	 2.6
	  	Expenses of Registration	  	 	10	  
		 	 2.7
	  	Delay of Registration	  	 	10	  
		 	 2.8
	  	Indemnification	  	 	10	  
		 	 2.9
	  	Reports Under Exchange Act	  	 	13	  
		 	 2.10  
	  	Limitations on Subsequent Registration Rights	  	 	13	  
		 	 2.11
	  	“Market Stand-off” Agreement	  	 	13	  
		 	 2.12
	  	Restrictions on Transfer	  	 	14	  
		 	 2.13
	  	Termination of Registration Rights	  	 	15	  
			
	 3.
	 	 Information Rights
	  	 	16	  
		 	 3.1
	  	Delivery of Financial Statements	  	 	16	  
		 	 3.2
	  	Inspection	  	 	17	  
		 	 3.3
	  	Termination of Information Rights	  	 	17	  
		 	 3.4
	  	Confidentiality	  	 	18	  
			
	 4.
	 	 Rights to Future Stock Issuances
	  	 	18	  
		 	 4.1
	  	Right of First Offer	  	 	18	  
		 	 4.2
	  	Termination	  	 	19	  
			
	 5.
	 	 Additional Covenants
	  	 	19	  
		 	 5.1
	  	Insurance	  	 	19	  
		 	 5.2
	  	Employee Agreements	  	 	20	  
		 	 5.3
	  	Vesting of Shares	  	 	20	  
		 	 5.4
	  	Board Matters	  	 	20	  
		 	 5.5
	  	Matters Requiring Approval of the Preferred Directors	  	 	20	  
		 	 5.6
	  	Successor Indemnification	  	 	21	  
		 	 5.7
	  	Termination of Covenants	  	 	21	  
			
	 6.
	 	 Miscellaneous
	  	 	22	  
		 	 6.1
	  	Successors and Assigns	  	 	22	  
		 	 6.2
	  	Governing Law	  	 	22	  
		 	 6.3
	  	Counterparts; Facsimile	  	 	22	  
		 	 6.4
	  	Titles and Subtitles	  	 	22	  
		 	 6.5
	  	Notices	  	 	22	  
		 	 6.6
	  	Amendments and Waivers	  	 	23	  


  
 (i) 









									
		 	 6.7
	  	Severability	  	 	23	  
		 	 6.8
	  	Aggregation of Stock	  	 	23	  
		 	 6.9
	  	Additional Investors	  	 	23	  
		 	 6.10  
	  	Entire Agreement; Termination of the Prior Agreement	  	 	24	  
		 	 6.11
	  	Arbitration	  	 	24	  
		 	 6.12
	  	Delays or Omissions	  	 	24	  
		 	 6.13
	  	Acknowledgment	  	 	24	  

 Schedule A - Schedule of Investors 

  
 (ii) 








 THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of
September 5, 2012, by and among Zendesk, Inc., a Delaware corporation (including its predecessors, the “Company”), and each of the investors listed on Schedule A hereto (each, an “Investor,” and
collectively, the “Investors”). 
 RECITALS 

WHEREAS, the Company and certain of the Investors have entered into a Series D Preferred Stock Purchase Agreement, dated as of the date hereof
(the “Purchase Agreement”); 
 WHEREAS, the Company and those Investors who hold shares of Series A Preferred Stock, Series
B Preferred Stock and Series C Preferred Stock are parties to a Second Amended and Restated Investors’ Rights Agreement, dated November 30, 2010 (the “Prior Agreement”); 

WHEREAS, in connection with the purchase and sale of shares of the Series D Preferred Stock pursuant to the Purchase Agreement, the Company
and the other parties to the Prior Agreement desire to amend and restate the Prior Agreement in its entirety as set forth herein; and 

WHEREAS, it is a condition precedent to the Company’s and Investors’ obligations under the Purchase Agreement that the Company and
the Investors enter into this Agreement in order, among other things, to provide the Investors with certain rights to cause the Company to register shares of Series A Common Stock issuable to the Investors, to receive certain information from the
Company and to participate in future equity offerings by the Company; 
 AGREEMENT 

NOW, THEREFORE, in consideration of these premises and for other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto agree as follows: 
 1. Definitions. For purposes of this Agreement: 

1.1 “Affiliate” means, with respect to any specified Person, any other Person who or which, directly or indirectly, controls,
is controlled by, or is under common control with such specified Person, including without limitation any general partner, member, officer, director, or manager of such Person and any venture capital fund now or hereafter existing that is controlled
by one or more general partners or managing members of, or shares the same management company or advisory company with, such Person. 
 1.2
“Common Stock” means shares of Series A Common Stock and Series B Common Stock. 

  
 1 








 1.3 “Damages” means any loss, damage, or liability (joint or several) to which a
party hereto may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such loss, damage, or liability (or any action in respect thereof) arises out of or is based upon (a) any untrue statement or
alleged untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto or any free writing prospectus;
(b) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or (c) any violation or alleged violation by the indemnifying party (or any of
its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law. 

1.4 “Derivative Securities” means any securities or rights convertible into, or exercisable or exchangeable for (in each
case, directly or indirectly), Common Stock, including, without limitation, options and warrants. 
 1.5 “Exchange Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. 
 1.6 “Excluded
Registration” means (a) a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase or similar plan; (b) a registration relating to an SEC Rule 145
transaction; (c) a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (d) a registration in
which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered. 

1.7 “Form S-1” means such form under the Securities Act as in effect on the date
hereof or any successor registration form under the Securities Act subsequently adopted by the SEC. 
 1.8 “Form S-3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial
information by reference to other documents filed by the Company with the SEC. 
 1.9 “GAAP” means generally accepted
accounting principles in the United States. 
 1.10 “Holder” means any holder of Registrable Securities who is a party to
this Agreement. 
 1.11 “Immediate Family Member” means a child, stepchild, grandchild, parent, stepparent, grandparent,
spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, of a natural person referred to herein. 

  
 2 








 1.12 “Initiating Holders” means, collectively, Holders who properly initiate a
registration request under this Agreement. 
 1.13 “IPO” means the Company’s first firm-commitment underwritten public
offering of its Series A Common Stock under the Securities Act. 
 1.14 “Major Investor” means any Investor that,
individually or together with such Investor’s Affiliates, holds at least 1,200,000 shares of Registrable Securities (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the
date hereof). 
 1.15 “New Securities” means any shares of equity securities of the Company, whether or not currently
authorized, as well as rights, options or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable for such equity securities. 

1.16 “Person” means any individual, corporation, partnership, trust, limited liability company, association or other entity.

 1.17 “Preferred Directors” means, collectively, the Series A Director, Series B Director and Series C Director. 

1.18 “Preferred Stock” means, collectively, the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock
and Series D Preferred Stock. 
 1.19 “Registrable Securities” means (a) the Series A Common Stock issuable or issued
upon conversion of the Preferred Stock held by the Investors; (b) any Series A Common Stock, or any Series A Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the Company
(including, for purposes of clarity, any shares of Series B Common Stock), acquired by the Investors after the date hereof; and (c) any Series A Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other
security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clauses (a) and (b) above; excluding, in all cases, however, any Registrable Securities sold by
a Person in a transaction in which the applicable rights under this Agreement are not assigned pursuant to Section 6.1, and excluding for purposes of Section 2 any shares for which registration rights have terminated pursuant
to Section 2.13. 
 1.20 “Registrable Securities then outstanding” means the number of shares at a point in
time determined by adding the number of shares of outstanding Series A Common Stock that are Registrable Securities at such time and the number of shares of Series A Common Stock issuable (directly or indirectly) at such time pursuant to then
exercisable and/or convertible securities that are Registrable Securities. 
 1.21 “Restated Certificate” means the
Company’s Sixth Amended and Restated Certificate of Incorporation, as may be amended from time to time. 

  
 3 








 1.22 “Restricted Securities” means the securities of the Company required to
bear the legend set forth in Section 2.12(b). 
 1.23 “SEC” means the Securities and Exchange Commission. 

1.24 “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act, or any successor provisions. 

1.25 “SEC Rule 144(b)(1)” means Rule 144(b)(1) promulgated by the SEC under the Securities Act, or any successor provisions.

 1.26 “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act, or any successor provisions. 

1.27 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 1.28 “Selling Expenses” means all underwriting discounts, selling commissions, and stock transfer taxes applicable to
the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in Section 2.6. 

1.29 “Selling Holder Counsel” shall have the meaning assigned to it in Section 2.6. 

1.30 “Series A Common Stock” means shares of the Company’s Series A Common Stock, par value $0.01 per share. 

1.31 “Series A Director” means any director of the Company that has been solely designated by the holders of record of the
Series A Preferred Stock pursuant to the Restated Certificate or the Third Amended and Restated Voting Agreement, dated as of the date hereof, between the Company, the Investors and certain other stockholders of the Company or otherwise. 

1.32 “Series A Preferred Stock” means shares of the Company’s Series A Preferred Stock, par value $0.01 per share. 

1.33 “Series B Common Stock” means shares of the Company’s Series B Common Stock, par value $0.01 per share. 

1.34 “Series B Director” means any director of the Company that has been solely designated by the holders of record of the
Series B Preferred Stock pursuant to the Restated Certificate or the Third Amended and Restated Voting Agreement, dated as of the date hereof, between the Company, the Investors and certain other stockholders of the Company or otherwise. 

1.35 “Series B Preferred Stock” means shares of the Company’s Series B Preferred Stock, par value $0.01 per share. 

  
 4 








 1.36 “Series C Director” means any director of the Company that has been solely
designated by the holders of record of the Series C Preferred Stock pursuant to the Restated Certificate or the Third Amended and Restated Voting Agreement, dated as of the date hereof, between the Company, the Investors and certain other
stockholders of the Company or otherwise. 
 1.37 “Series C Preferred Stock” means shares of the Company’s Series C
Preferred Stock, par value $0.01 per share. 
 1.38 “Series D Preferred Stock” means shares of the Company’s Series D
Preferred Stock, par value $0.01 per share. 
 2. Registration Rights. The Company covenants and agrees as follows: 

2.1 Demand Registration. 

(a) Form S-1 Demand. Beginning upon the earlier of (i) five (5) years after the date of this Agreement or (ii) one
hundred eighty (180) days after the effective date of the registration statement for the IPO, if the Company receives a request from Holders of at least fifty-one percent (51%) of the Registrable Securities then outstanding (a
“Preferred Interest”) that the Company file a Form S-1 registration statement with respect to all or part of the Registrable Securities of such Holders having an anticipated aggregate offering price, net of Selling Expenses, of at
least thirty million dollars ($30,000,000), then the Company shall (i) within ten (10) days after the date such request is given, give notice thereof (the “Demand Notice”) to all Holders other than the Initiating Holders;
and (ii) as soon as practicable, and in any event within sixty (60) days after the date such request is given by the Initiating Holders, file a Form S-1 registration statement under the Securities Act covering all Registrable Securities
that the Initiating Holders requested to be registered and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty
(20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Section 2.1(c) and Section 2.3. 

(b) Form S-3 Demand. If at any time when it is eligible to use a Form S-3 registration statement, the Company receives a request
from Holders of at least a Preferred Interest that the Company file a Form S-3 registration statement with respect to all or part of the Registrable Securities of such Holders having an anticipated aggregate offering price, net of Selling Expenses,
of at least ten million dollars ($10,000,000), then the Company shall (i) within ten (10) days after the date such request is given, give a Demand Notice to all Holders other than the Initiating Holders; and (ii) as soon as
practicable, and in any event within forty-five (45) days after the date such request is given by the Initiating Holders, file a Form S-3 registration statement under the Securities Act covering all Registrable Securities that the Initiating
Holders requested to be registered and an additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date
the Demand Notice is given, and in each case, subject to the limitations of Section 2.1(c) and Section 2.3. 

  
 5 








 (c) Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a
registration pursuant to this Section 2.1 a certificate signed by the Company’s chief executive officer stating that, in the good faith judgment of the Company’s Board of Directors, it would be materially detrimental to the
Company and its stockholders for such registration statement to either become effective or remain effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i) materially
interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature disclosure of material information that the Company has a bona fide business purpose for preserving
as confidential; or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking action with respect to such filing, and any time periods with
respect to filing or effectiveness thereof shall be tolled correspondingly, for a period of not more than sixty (60) days after the request of the Initiating Holders is given; provided, however, that the Company may not invoke
this right more than once in any twelve (12) month period; provided, further that the Company shall not register any securities for its own account or that of any other stockholder during such sixty (60) day period, other
than an Excluded Registration. 
 (d) The Company shall not be obligated to effect, or to take any action to effect, any registration
pursuant to Section 2.1(a) (i) during the period that is sixty (60) days before the Company’s good faith estimate of the date of filing of, and ending on a date that is one hundred eighty (180) days after the
effective date of, a Company-initiated registration, subject to Section 2.2 below, provided, that the Company is actively employing its good faith commercially reasonable efforts to cause such registration statement to become
effective; (ii) after the Company has effected two (2) registrations pursuant to Section 2.1(a); or (iii) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered
on Form S-3 pursuant to a request made pursuant to Section 2.1(b). The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Section 2.1(b) (i) during the period that is
thirty (30) days before the Company’s good faith estimate of the date of filing of, and ending on a date that is ninety (90) days after the effective date of, a Company-initiated registration relating to shares to be sold by the
Company, subject to Section 2.2 below, provided, that the Company is actively employing its good faith commercially reasonable efforts to cause such registration statement to become effective; or (ii) if the Company has
effected two (2) registrations pursuant to Section 2.1(b) within the twelve (12) month period immediately preceding the date of such request. A registration shall not be counted as “effected” for purposes of this
Section 2.1(d) until such time as the applicable registration statement has been declared effective by the SEC, unless the Initiating Holders withdraw their request for such registration (other than as a result of a material adverse
change to the Company, in which case such registration shall not be deemed to have been “effected”), elect not to pay the registration expenses therefor, and forfeit their right to one demand registration statement pursuant to
Section 2.6, in which case such withdrawn registration statement shall be counted as “effected” for purposes of this Section 2.1(d). 

2.2 Company Registration. If the Company proposes to register (including, for this purpose, a registration effected by the Company for
stockholders other than the Holders) any of its securities under the Securities Act in connection with a public offering of such securities solely for cash (other than in an Excluded Registration), the Company shall, at such


  
 6 








 
time, promptly give each Holder notice of such registration. Upon the request of each Holder given within twenty (20) days after such notice is given by the Company, the Company shall,
subject to the provisions of Section 2.3, cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration. The Company shall have the right to terminate or withdraw any
registration initiated by it under this Section 2.2 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration. The expenses (other than Selling Expenses)
of such withdrawn registration shall be borne by the Company in accordance with Section 2.6. 
 2.3 Underwriting
Requirements. 
 (a) If, pursuant to Section 2.1, the Initiating Holders intend to distribute the Registrable Securities
covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Section 2.1, and the Company shall include such information in the Demand Notice. The underwriter(s) will
be selected by the Company and shall be reasonably acceptable to a two-thirds interest of the Initiating Holders. In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be conditioned
upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such
underwriting shall (together with the Company as provided in Section 2.4(e)) enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting. Notwithstanding any other provision of this
Section 2.3, if the underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable
Securities that otherwise would be underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in
proportion (as nearly as practicable) to the number of Registrable Securities owned by each such selling Holder or in such other proportion as shall mutually be agreed to by all such selling Holders; provided, however, that the number
of Registrable Securities held by the Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares in accordance with the above
provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest one hundred (100) shares. 

(b) In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to
Section 2.2, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company and its
underwriter(s), and then only in such quantity as the underwriter(s) determine in good faith will not jeopardize the success of the offering by the Company. If the total number of securities, including Registrable Securities, requested by
stockholders to be included in such offering exceeds the number of securities to be sold (other than by the Company) that the underwriter(s) in their reasonable discretion determine is compatible with the success of the offering, then the Company
shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriter(s) determine in good faith will not 

  
 7 








 
jeopardize the success of the offering. If the underwriter(s) determine in good faith that less than all of the Registrable Securities requested to be registered can be included in such offering,
then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable to) the number of Registrable Securities owned by each such selling Holder or in such other
proportions as shall mutually be agreed to by all such selling Holders. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriter(s) may round the number of shares allocated to any Holder to the
nearest one hundred (100) shares. Notwithstanding the foregoing, in no event shall (i) the number of Registrable Securities included in the offering be reduced unless all other securities (other than securities to be sold by the Company)
are first entirely excluded from the offering, or (ii) the number of Registrable Securities included in the offering be reduced below thirty percent (30%) of the total number of securities included in such offering, unless such offering is
the IPO, in which case the selling Holders may be excluded further if the underwriter(s) make the determination described above and no other stockholder’s securities are included in such offering. For purposes of the provision in this
Section 2.3(b) concerning apportionment, for any selling Holder that is a partnership, limited liability company or corporation, the partners, members, retired partners, retired members, stockholders and Affiliates of such Holder, or the
estates and Immediate Family Members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a single “selling Holder,” and any pro rata
reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,” as defined in this sentence. 

(c) For purposes of Section 2.1, a registration shall not be counted as “effected” if, as a result of an exercise of the
underwriter’s cutback provisions in Section 2.3(a), fewer than fifty percent (50%) of the total number of Registrable Securities that Holders have requested to be including in such registration statement are actually included. 

2.4 Obligations of the Company. Whenever required under this Section 2 to effect the registration of any Registrable
Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) prepare and file with the SEC a registration statement with
respect to such Registrable Securities and use its commercially reasonable efforts to cause such registration statement to become effective and, upon the request of the Holders of at least a majority of the Registrable Securities registered
thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however,
that (i) such one hundred twenty (120) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Series A Common Stock (or other securities) of the Company, from selling
any securities included in such registration and (ii) in the case of a registration of Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such
one hundred twenty (120) day period shall be extended up to one hundred eighty (180) days, if necessary, to keep the registration statement effective until all such Registrable Securities are sold; 

  
 8 








 (b) prepare and file with the SEC such amendments and supplements to such registration
statement, and the prospectus used in connection with such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such registration statement; 

(c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities
Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided, however, that the Company shall not be required to qualify to do business or to file a general consent to service of
process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the underwriter(s) of such offering; 
 (f) use its commercially reasonable efforts to cause all such Registrable
Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; 

(g) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number
for all such Registrable Securities, in each case not later than the effective date of such registration; 
 (h) promptly make available
for inspection by the selling Holders, any underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders,
all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information reasonably requested by any such
seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; 

(i) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been
declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and 
 (j) after such
registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company amend or supplement such registration statement or prospectus. 

  
 9 








 2.5 Furnish Information. It shall be a condition precedent to the obligations of the
Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by
it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities. 

2.6 Expenses of Registration. All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or
qualifications pursuant to Section 2, including all registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one
(1) counsel for the selling Holders (“Selling Holder Counsel”) selected by the Holders of a majority of the Registrable Securities to be registered in such registration, shall be borne and paid by the Company; provided,
however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.1 if the registration request is subsequently withdrawn at the request of the Holders of at least a
majority of the Registrable Securities to be registered (in which case all selling Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless the Holders
of at least a Preferred Interest of the Registrable Securities agree to forfeit their right to one (1) registration pursuant to Section 2.1(a) or Section 2.1(b), as the case may be; provided, further that
if, at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with
reasonable promptness after learning of such information, then the Holders shall not be required to pay any of such expenses and shall not forfeit their right to one (1) registration pursuant to Section 2.1(a) or
Section 2.1(b). All Selling Expenses relating to Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders of the Registrable Securities to which such Selling Expenses relate. 

2.7 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any
registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.8 Indemnification. If any Registrable Securities are included in a registration statement under this Section 2: 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each selling Holder, and the partners, members, officers,
directors and stockholders of each such Holder, legal counsel and accountants for each such Holder, any underwriter (as defined in the Securities Act) for each such Holder and each Person, if any, who controls such Holder or underwriter within the
meaning of the Securities Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person or other aforementioned Person any legal or other expenses reasonably incurred thereby in
connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Section 2.8(a) shall not
apply to amounts paid in settlement of any 

  
 10 








 
such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable for any Damages to
the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of any such Holder, underwriter, controlling Person or other aforementioned Person
expressly for use in connection with such registration. 
 (b) To the extent permitted by law, each selling Holder, severally and not
jointly, will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal counsel
and accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement and any controlling Person of any such underwriter or other Holder, against any Damages, in each
case, only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in connection with
such registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which
Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Section 2.8(b) shall not apply to amounts paid in settlement of any such claim or proceeding if such
settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; and provided, further that in no event shall any indemnity under this Section 2.8(b), when combined with any
amounts paid or payable under Section 2.8(e), exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by such Holder. 

(c) Promptly after receipt by an indemnified party under this Section 2.8 of notice of the commencement of any action (including
any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.8, give the
indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other indemnifying party to which
notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without
conflict by one counsel) shall have the right to retain one (1) separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party
would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the indemnifying party within a reasonable time of the
commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this Section 2.8, to the extent that such failure materially prejudices the indemnifying party’s ability to defend
such action. The failure to give notice to the indemnifying party will not relieve the indemnifying party of any liability that it may have to any indemnified party otherwise than under this Section 2.8. 

  
 11 








 (d) Notwithstanding anything else herein to the contrary, the foregoing indemnity agreements of
the Company and the selling Holders are subject to the condition that, insofar as they relate to any Damages arising from any untrue statement or alleged untrue statement of a material fact contained in, or omission or alleged omission of a material
fact from, a preliminary prospectus (or necessary to make the statements therein not misleading) that has been corrected in the form of prospectus included in the registration statement at the time it becomes effective, or any amendment or
supplement thereto filed with the SEC pursuant to Rule 424(b) under the Securities Act (the “Final Prospectus”), such indemnity agreement shall not inure to the benefit of any Person if a copy of the Final Prospectus was furnished
to the indemnified party and such indemnified party failed to deliver, at or before the confirmation of the sale of the shares registered in such offering, a copy of the Final Prospectus to the Person asserting the loss, liability, claim, or damage
in any case in which such delivery was required by the Securities Act and such delivery would have prevented such Damages. 
 (e) To
provide for just and equitable contribution to joint liability under the Securities Act in any case in which either (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this
Section 2.8 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may
not be enforced in such case, notwithstanding the fact that this Section 2.8 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which
indemnification is provided under this Section 2.8, then, and in each such case, such parties will contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from
others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage,
liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or
allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission; provided, however, that, in any such case, (x) no Holder will be required to contribute any amount in excess of the proceeds from the offering received
by such Holder (net of any Selling Expenses paid by such Holder), and (y) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was
not guilty of such fraudulent misrepresentation; provided, further that in no event shall a Holder’s liability pursuant to this Section 2.8(e), when combined with the amounts paid or payable by such Holder pursuant to
Section 2.8(b), exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder. 

(f) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

  
 12 








 (g) Unless otherwise superseded by an underwriting agreement entered into in connection with the
underwritten public offering, the obligations of the Company and Holders under this Section 2.8 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall
survive the termination of this Agreement. 
 2.9 Reports Under Exchange Act. With a view to making available to the Holders the
benefits of SEC Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form
S-3, the Company shall: 
 (a) make and keep available adequate current public information, as those
terms are understood and defined in SEC Rule 144, at all times after the effective date of the registration statement filed by the Company for the IPO; 

(b) use commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under
the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and 
 (c)
furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) to the extent accurate, a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any
time after ninety (90) days after the effective date of the registration statement filed by the Company for the IPO), the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements) or
that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after the Company so qualifies); (ii) a copy of the most recent annual or quarterly report of the Company
and such other reports and documents so filed by the Company; and (iii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without
registration (at any time after the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to Form S-3 (at any time after the Company so qualifies to use such form). 

2.10 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the prior
written consent of the Holders of at least a Preferred Interest, enter into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective holder (a) to include such securities
in any registration unless, under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of such securities will not reduce the number of the
Registrable Securities of the Holders that are included or (b) to demand registration of any securities held by such holder or prospective holder; provided, however, that this limitation shall not apply to any additional Investor
who becomes a party to this Agreement in accordance with Section 6.9. 
 2.11 “Market
Stand-off” Agreement. Each Holder hereby agrees that, if required by the managing underwriter, it will not, during the period commencing on the date of


  
 13 








 
the final prospectus relating to the IPO and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days, which period
may be extended upon the request of the managing underwriter for an additional period of up to fifteen (15) days if the Company issues or proposes to issue an earnings or other public release within fifteen (15) days of the expiration of
the one hundred eighty (180) day lockup period), lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer
or dispose of, directly or indirectly, any shares of Series A Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Series A Common Stock held immediately before the effective date of the
registration statement for such offering. The foregoing provisions of this Section 2.11 shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement and shall be applicable to the Holders only if all
officers, directors and stockholders individually owning more than one percent (1%) of the Company’s outstanding Series A Common Stock (after giving effect to conversion into Series A Common Stock of all outstanding shares of Preferred
Stock and Series B Common Stock) are subject to the same restrictions. The underwriters in connection with such registration are intended third-party beneficiaries of this Section 2.11 and shall
have the right, power and authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration
that are consistent with this Section 2.11 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply
pro rata to all Holders subject to such agreements, based on the number of shares subject to such agreements. 
 2.12 Restrictions on
Transfer. 
 (a) The Preferred Stock and the Registrable Securities shall not be sold, pledged or otherwise transferred, and the Company
shall not recognize any such sale, pledge or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure compliance with the provisions of the Securities Act. A transferring Holder will cause any
proposed purchaser, pledgee or transferee of the Preferred Stock and the Registrable Securities held by such Holder to agree to take and hold such securities subject to the provisions and upon the conditions specified in this Agreement. 

(b) Each certificate or instrument representing (i) the Preferred Stock, (ii) the Registrable Securities and (iii) any other
securities issued in respect of the securities referenced in clauses (i) and (ii) above, upon any stock split, stock dividend, recapitalization, merger, consolidation, or similar event, shall (unless otherwise permitted by the
provisions of Section 2.12(c)) be stamped or otherwise imprinted with a legend substantially in the following form: 
 THE
SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SHARES MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION
FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. 

  
 14 








 THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN
AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 
 THE SECURITIES
REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AFTER THE EFFECTIVE DATE OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE
SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 
 The
Holders consent to the Company making a notation in its records and giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this Section 2.12. 

(c) The holder of each certificate representing Restricted Securities, by acceptance thereof, agrees to comply in all respects with the
provisions of this Section 2. Before any proposed sale, pledge or transfer of any Restricted Securities, unless there is in effect a registration statement under the Securities Act covering the proposed transaction, the Holder thereof
shall give notice to the Company of such Holder’s intention to effect such sale, pledge or transfer. Each such notice shall describe the manner and circumstances of the proposed sale, pledge or transfer in sufficient detail and, if reasonably
requested by the Company, shall be accompanied at such Holder’s expense by either (i) a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to the Company, to the
effect that the proposed transaction may be effected without registration under the Securities Act; (ii) a “no action” letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted Securities without
registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (iii) any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed sale, pledge, or
transfer of the Restricted Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities shall be entitled to sell, pledge, or transfer such Restricted Securities in accordance with the
terms of the notice given by the Holder to the Company. The Company will not require such a legal opinion or “no action” letter (x) in any transaction in compliance with SEC Rule 144 or (y) in any transaction in which such Holder
distributes Restricted Securities to an Affiliate of such Holder for no consideration; provided that each transferee pursuant to clause (y) agrees in writing to be subject to the terms of this Section 2.12. Each certificate or
instrument evidencing the Restricted Securities transferred as above provided shall bear, except if such transfer is made pursuant to SEC Rule 144, the appropriate restrictive legend set forth in Section 2.12(b), except that such
certificate shall not bear such restrictive legend if, in the opinion of counsel for such Holder and the Company, such legend is not required in order to establish compliance with any provisions of the Securities Act. 

2.13 Termination of Registration Rights. The right of any Holder to request registration or inclusion of Registrable Securities in any
registration pursuant to Section 2.1 or  

  
 15 








 
Section 2.2 shall terminate upon the closing of a Deemed Liquidation Event (as defined in the Restated Certificate) pursuant to which the Investors receive cash and/or marketable
securities, or the later to occur of: 
 (a) such time following the IPO when all of such Holder’s Registrable Securities could be sold
without restriction under SEC Rule 144(b)(1) within any ninety (90) day period; or 
 (b) the fifth (5th) anniversary of the Company’s first Qualified Public Offering (as defined in the Restated Certificate). 

3. Information Rights. 

3.1 Delivery of Financial Statements. The Company shall deliver (i) to each Major Investor (in each case including a copy to
crvfinance@crv.com) the information set forth in Subsections (a) – (f) below and (ii) to GS Direct, L.L.C. (“GS”) the information set forth in Subsections (a) and (b) below: 

(a) as soon as practicable, but in any event within ninety (90) days after the end of each fiscal year of the Company, (i) a balance
sheet as of the end of such year, (ii) statements of income and of cash flows for such year, and a comparison between (x) the actual amounts as of and for such fiscal year and (y) the comparable amounts for the prior year and as
included in the Budget (as defined in Section 3.1(e)) for such year, with an explanation of any material differences between such amounts and a schedule as to the sources and applications of funds for such year; and (iii) a
statement of stockholders’ equity as of the end of such year, all such financial statements audited and certified by independent public accountants selected by the Company and approved by the Board of Directors, which approval shall include the
approval of at least two of the Preferred Directors; 
 (b) as soon as practicable, but in any event within
forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, unaudited statements of income and of cash flows for such fiscal quarter, and an
unaudited balance sheet and a statement of stockholders’ equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial reports may (i) be subject to normal year-end audit adjustments and
(ii) not contain all notes thereto that may be required in accordance with GAAP); 
 (c) as soon as practicable, but in any event
within forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, a statement showing the number of shares of each class and series of capital stock and securities convertible into or
exercisable for shares of capital stock outstanding at the end of the period, the Common Stock issuable upon conversion or exercise of any outstanding securities convertible or exercisable for Common Stock and the exchange ratio or exercise price
applicable thereto, and the number of shares of issued stock options and stock options not yet issued but reserved for issuance, if any, all in sufficient detail as to permit the Investors to calculate their respective percentage equity ownership in
the Company, and certified by the chief financial officer or chief executive officer of the Company as being true, complete, and correct; 

  
 16 








 (d) as soon as practicable, but in any event within thirty (30) days of the end of each
month, an unaudited income statement and statement of cash flows for such month, and an unaudited balance sheet as of the end of such month (“Monthly Financials”), all prepared in accordance with GAAP (except that such financial
statements may (i) be subject to normal year-end audit adjustments and (ii) not contain all notes thereto that may be required in accordance with GAAP); provided, however, that the Company shall have no obligation to deliver
such Monthly Financials until such time that the Company undertakes to prepare monthly financials reports; 
 (e) as soon as practicable,
but in any event thirty (30) days before the end of each fiscal year, a budget and business plan for the next fiscal year (collectively, the “Budget”), prepared on a monthly basis, including balance sheets, income statements,
and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets or forecasts prepared by the Company; and including, in each case, any revisions thereto; and 

(f) as soon as practicable, any reports or analyses concerning the fair market value of the Common Stock, whether prepared by Company
employees or third parties; provided, however, the Company shall have no obligation to disclose any report prepared by third parties if such disclosure is prohibited by the terms of such report or analysis. 

If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial
statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. 

Notwithstanding anything in this Section 3.1 to the contrary, the Company may cease providing the information set forth in this
Section 3.1 during the period starting with the date thirty (30) days before the Company’s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC
rules applicable to such registration statement and related offering; provided, however, that the Company’s covenants under this Section 3.1 shall be reinstated at such time as the Company is no longer actively
employing its commercially reasonable efforts to cause such registration statement to become effective. 
 3.2 Inspection. The
Company shall permit each Major Investor, at such Major Investor’s expense, to visit and inspect the Company’s properties, examine its books of account and records and discuss the Company’s affairs, finances, and accounts with its
officers, during normal business hours of the Company as may be reasonably requested by the Major Investor; provided, however, that the Company shall not be obligated pursuant to this Section 3.2 to provide access to any
information that it reasonably considers to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in form acceptable to the Company) or the disclosure of which would adversely affect the
attorney-client privilege between the Company and its counsel. 
 3.3 Termination of Information Rights. The covenants set forth in
Section 3.1 and Section 3.2 shall terminate and be of no further force or effect (a) immediately before, but 

  
 17 








 
subject to, the consummation of the IPO or (b) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, whichever
event occurs first. 
 3.4 Confidentiality. Each Investor agrees that such Investor will keep confidential and will not disclose,
divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company’s intention to file a
registration statement), unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 3.4 by such Investor), (b) is or has been independently
developed or conceived by the Investor without use of the Company’s confidential information or (c) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third
party may have to the Company; provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants and other professionals to the extent necessary to obtain their services in
connection with monitoring its investment in the Company; (ii) to any existing or prospective purchaser of any Registrable Securities from such Investor, if such purchaser agrees to be bound by the provisions of this Section 3.4;
(iii) to any existing or prospective Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor informs such Person that such information is
confidential and directs such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law or pursuant to regulatory requests, provided that the Investor promptly notifies the Company of such
disclosure and takes reasonable steps to minimize the extent of any such required disclosure. Notwithstanding the foregoing, nothing in this Section 3.4 shall restrict the ability of any Investor that is an investment fund to disclose the
existence and nature of its relationship with the Company to its affiliates, members or partners, or to provide its affiliates, members, limited partners or partners with periodic reports and such other financial information about the Company
prepared by such Investor in the ordinary course of its business. 
 4. Rights to Future Stock Issuances. 

4.1 Right of First Offer. Subject to the terms and conditions of this Section 4.1 and applicable securities laws, if the
Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to each Major Investor and GS. A Major Investor and GS shall be entitled to apportion the right of first offer hereby granted to it among itself
and its Affiliates in such proportions as it deems appropriate. 
 (a) The Company shall give notice (the “Offer Notice”)
to each Investor, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered and (iii) the price and terms, if any, upon which it proposes to offer such New Securities. 

(b) By notification to the Company within twenty (20) days after the Offer Notice is given, each Major Investor and GS may elect to
purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the Registrable Securities and any other Derivative Securities


  
 18 








 
then held by such Investor bears to the total Common Stock then outstanding (assuming full conversion and/or exercise, as applicable, of all Preferred Stock and other Derivative Securities). At
the expiration of such twenty (20) day period, the Company shall promptly notify each Major Investor that elects, and GS if it elects, to purchase or acquire all the shares available to it (each, a “Fully Exercising Investor”)
of any other Major Investor’s or GS’s failure to do likewise. During the ten (10) day period commencing after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase or
acquire, in addition to the number of shares specified above, up to that portion of the New Securities for which Major Investors and GS were entitled to subscribe but that were not subscribed for by the Major Investors and GS which is equal to the
proportion that the Registrable Securities and any other Derivative Securities then held by such Fully Exercising Investor bears to the Registrable Securities and any other Derivative Securities then held, by all Fully Exercising Investors who wish
to purchase such unsubscribed shares or in such other proportion as shall be agreed among the Fully Exercising Investors. The closing of any sale pursuant to this Section 4.1(b) shall occur within the later of one hundred twenty (120)
days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to Section 4.1(d). 

(c) If all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in
Section 4.1(b), the Company may, during the ninety (90) day period following the expiration of the periods provided in Section 4.1(b), offer and sell the remaining unsubscribed portion of such New Securities to any
Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such
agreement is not consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major Investors and GS in
accordance with this Section 4.1. 
 (d) The right of first offer in this Section 4.1 shall not be applicable to
(i) Exempted Securities (as defined in the Restated Certificate), (ii) shares of Series A Common Stock issued in a Qualified Public Offering (as defined in the Restated Certificate) and (iii) shares of Series D Preferred Stock issued
pursuant to the Purchase Agreement. 
 4.2 Termination. The covenants set forth in Section 4.1 shall terminate and be of
no further force or effect (i) immediately before, but subject to, the consummation of a Qualified Public Offering (as defined in the Restated Certificate) or (ii) when the Company first becomes subject to the periodic reporting
requirements of Section 12(g) or 15(d) of the Exchange Act, whichever event occurs first. 
 5. Additional Covenants. 

5.1 Insurance. The Company shall use its commercially reasonable efforts to obtain, from financially sound and reputable insurers
(a) directors and officers’ liability insurance and (b) term “key-person” insurance on each of Alexander Aghassipour, Morten Primdahl and Mikkel Svane (each, a “Founder”), in each case, in an amount and on
terms and conditions satisfactory to the Board of Directors (including at least two of the Preferred Directors), and will use commercially reasonable efforts to cause such insurance policies to be 

  
 19 








 
maintained until such time as the Board of Directors (including at least two of the Preferred Directors) determines that such insurance should be discontinued. The “key-person”
insurance policy shall name the Company as loss payee, and neither policy shall be cancelable by the Company without the prior approval of the Board of Directors (including at least two of the Preferred Directors). 

5.2 Employee Agreements. The Company will cause each person now or hereafter employed by it or by any subsidiary (or engaged by the
Company or any subsidiary as a consultant or independent contractor) with access to confidential information and/or trade secrets of the Company to enter into a nondisclosure and proprietary rights assignment agreement in the form approved by the
Company’s Board of Directors. 
 5.3 Vesting of Shares. Unless otherwise approved by the Board of Directors (including at least
two of the Preferred Directors), all future employees and consultants of the Company who purchase, receive options to purchase, or receive awards of shares of the Company’s capital stock after the date hereof shall be required to execute
restricted stock or option agreements, as applicable, providing for (a) vesting of shares over a four (4) year period, with the first twenty-five percent (25%) of such shares vesting following twelve (12) months of continued
employment or service and the remaining shares vesting in equal monthly installments over the following thirty-six (36) months and (b) a market stand-off provision substantially similar to that in Section 2.11. The Company
shall retain a right of first refusal on transfers until the Company’s IPO and the right to repurchase unvested shares at cost. 
 5.4
Board Matters. Unless otherwise determined by the vote of a majority of the directors then in office (including at least two of the Preferred Directors), the Board of Directors shall meet at least quarterly in accordance with an agreed-upon
schedule. The Company shall reimburse the non-employee directors for all reasonable out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board of Directors. Except to
the extent its fiduciary duties require otherwise, the Board of Directors shall cause each of the Preferred Directors, if each such person so elects, to be appointed to each committee of the Board of Directors. 

5.5 Matters Requiring Approval of the Preferred Directors. So long as (i) the holders of Series A Preferred Stock are entitled to
elect a Series A Director, (ii) the holders of Series B Preferred Stock are entitled to elect a Series B Director or (iii) the holders of Series C Preferred Stock are entitled to elect a Series C Director, the Company hereby covenants and
agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval must include the affirmative vote a majority of the Preferred Directors: 

(a) make, or permit any subsidiary to make, any loan or advance to, or own any stock or other securities of, any subsidiary or other
corporation, partnership or other entity unless it is wholly owned by the Company; 
 (b) make, or permit any subsidiary to make, any loan
or advance in excess of $100,000 to any Person, including, without limitation, any employee or director of the Company or any subsidiary, except advances and similar expenditures in the ordinary course of


  
 20 








 
business or under the terms of an employee stock or option plan approved by the Board of Directors; 

(c) guarantee, directly or indirectly, or permit any subsidiary to guarantee, directly or indirectly, any indebtedness, except for trade
accounts of the Company or any subsidiary arising in the ordinary course of business; 
 (d) implement (or amend) any cash investment
policy or make any investment inconsistent with any such investment policy; 
 (e) incur any aggregate indebtedness in excess of $500,000
that is not already included in a budget approved by the Board of Directors, other than trade credit incurred in the ordinary course of business; 

(f) otherwise enter into or be a party to any transaction with any director, officer or employee of the Company or any “associate”
(as defined in Rule 12b-2 promulgated under the Exchange Act) of any such Person, except for transactions contemplated by this Agreement or the Purchase Agreement; 

(g) hire, terminate, or materially change the compensation of any executive officer of the Company, including approving any option grants or
stock awards to any executive officer of the Company; 
 (h) change the principal business of the Company, enter into new lines of business
or exit the current line of business; or 
 (i) sell, assign, license, pledge or encumber material technology or intellectual property of
the Company or any subsidiary, other than licenses granted in the ordinary course of business. 
 5.6 Successor Indemnification. If
the Company or any of its successors or assignees consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be
made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are
contained in the Company’s Bylaws, the Restated Certificate or elsewhere, as the case may be. 
 5.7 Termination of Covenants.
The covenants set forth in this Section 5, except for Section 5.6, shall terminate and be of no further force or effect (i) immediately before but subject to the consummation of a Qualified Public Offering,
(ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event (as defined in the Restated Certificate) pursuant to which the
Investors receive cash and/or marketable securities, whichever event occurs first. 

  
 21 








 6. Miscellaneous. 

6.1 Successors and Assigns. The rights under this Agreement may be assigned (but only with all related obligations) by a Holder to a
transferee of Registrable Securities that (a) is an Affiliate, partner, member, limited partner, retired partner, retired member, or stockholder of a Holder; (b) is a Holder’s Immediate Family Member or trust for the benefit of an
individual Holder or one or more of such Holder’s Immediate Family Members; or (c) after such transfer, holds at least four hundred thousand (400,000) shares of Registrable Securities (subject to appropriate adjustment for stock
splits, stock dividends, combinations, and other recapitalizations); provided, however, that (i) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such
transferee and the Registrable Securities with respect to which such rights are being transferred; and (ii) such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this
Agreement, including the provisions of Section 2.11. For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (A) that is an Affiliate, limited partner,
retired partner, member, retired member, or stockholder of a Holder; (B) who is a Holder’s Immediate Family Member; or (C) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member shall be
aggregated together and with those of the transferring Holder; provided further that all transferees who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any
rights, receiving notices, or taking any action under this Agreement. The terms and conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this
Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as
expressly provided herein. 
 6.2 Governing Law. This Agreement shall be governed by and construed in accordance with the General
Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the State of Delaware, without regard to its principles of
conflicts of laws. 
 6.3 Counterparts; Facsimile. This Agreement may also be executed and delivered by facsimile signature and in
two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

6.4 Titles and Subtitles. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in
construing or interpreting this Agreement. 
 6.5 Notices. All notices, requests, and other communications given or made pursuant to
this Agreement shall be in writing and shall be deemed effectively given, delivered and received (a) upon personal delivery to the party to be notified; (b) when sent by confirmed electronic mail or facsimile if sent during normal business
hours of the recipient, and if not so confirmed, then on the next business day; (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one (1) business day
after the business day of deposit with a nationally recognized overnight courier, specifying next-day delivery, with written verification of receipt, and for international parties, when sent with an internationally recognized courier, three
(3) days after deposit. All communications shall be sent to the respective parties at their addresses as set forth on the signature pages hereto or to such 

  
 22 








 
email address, facsimile number, or address as subsequently modified by written notice given in accordance with this Section 6.5. All communications to the Company shall be sent to
989 Market St., Ste. 300, San Francisco, California, 94103, Attention: General Counsel, with a copy (which shall not constitute notice) to Goodwin Procter LLP, Exchange Place, 53 State Street, Boston, MA 02109, Attention: William J. Schnoor, Jr.,
Esq., Facsimile No: 617-523-1231. 
 6.6 Amendments and Waivers. Any term of this Agreement, including without limitation
Section 4.1, may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the
holders of at least a fifty-one percent (51%) of the Registrable Securities then outstanding; provided, however, that the Company may in its sole discretion waive compliance with Section 2.12(c) (and the Company’s
failure to object promptly in writing after notification of a proposed assignment allegedly in violation of Section 2.12(c) shall be deemed to be a waiver); provided, further, that any provision hereof may be waived by any
waiving party on such party’s own behalf, without the consent of any other party. Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any
Investor without the written consent of such Investor, unless such amendment, termination, or waiver applies to all Investors in the same fashion (it being agreed that a waiver of the provisions of Section 4 with respect to a particular
transaction shall be deemed to apply to all Investors in the same fashion if such waiver does so by its terms, notwithstanding the fact that certain Investors may nonetheless, by agreement with the Company, purchase securities in such transaction).
The Company shall give prompt notice of any amendment or termination hereof or waiver hereunder to any party hereto that did not consent in writing to such amendment, termination, or waiver. Any amendment, termination, or waiver effected in
accordance with this Section 6.6 shall be binding on all parties hereto, regardless of whether any such party has consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more
instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision. 
 6.7
Severability. In case any one or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other
provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 

6.8 Aggregation of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the
purpose of determining the availability of any rights under this Agreement. 
 6.9 Additional Investors. Notwithstanding anything to
the contrary contained herein, if the Company issues additional shares of the Company’s Preferred Stock after the date hereof, any purchaser of such shares of Preferred Stock may become a party to this Agreement by executing and delivering an
additional counterpart signature page to this Agreement, and thereafter shall be deemed an “Investor” for all purposes hereunder. No action or consent by the Investors shall be required for such joinder to this Agreement by such additional
Investor, so 

  
 23 








 
long as such additional Investor has agreed in writing to be bound by all of the obligations as an “Investor” hereunder. 

6.10 Entire Agreement; Termination of the Prior Agreement. This Agreement (including any Schedules and Exhibits hereto) constitutes the
full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled. Upon the
effectiveness of this Agreement, the Prior Agreement shall terminate and be of no further force and effect, and shall be superseded and replaced in its entirety by this Agreement. 

6.11 Arbitration. The parties agree first to negotiate in good faith to resolve any disputes arising out of or relating to or affecting
the subject matter of this Agreement. Any dispute arising out of or relating to or affecting the subject matter of this Agreement not resolved by negotiation shall be settled by binding arbitration in Santa Clara County, California before the
Judicial Arbitration and Mediation Services, Inc. (“JAMS”) under the JAMS Rules of Practice and Procedure. The arbitrator shall be a former judge of a court of California. Discovery and other procedural matters shall be governed as
though the proceeding were an arbitration. Any judgment upon the award may be confirmed and entered in any court having jurisdiction thereof. The arbitrator shall be required to, in all determinations, apply California law without regard to its
conflicts of law provisions. Notwithstanding the foregoing, the arbitrator shall apply the substantive law of the state of incorporation of the Company, where applicable. The arbitrator is afforded the jurisdiction to order any provisional remedies,
including, without limitation, injunctive relief. The arbitrator may award the prevailing party the costs of arbitration, including reasonable attorneys’ fees and expenses. The arbitrator’s award shall be in writing and shall state the
reasons for the award. The parties stipulate that a JAMS employee may be appointed as a judge pro tempore of the Superior Court of Santa Clara County if required to carry out the terms of this provision. Arbitration shall be the sole and exclusive
means to resolve any dispute. 
 6.12 Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to
any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or
acquiescence to any such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All
remedies, whether under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 
 6.13
Acknowledgment. The Company acknowledges that the Investors are in the business of venture capital investing and therefore review the business plans and related proprietary information of many enterprises, including enterprises which may have
products or services which compete directly or indirectly with those of the Company. Nothing in this Agreement shall preclude or in any way restrict the Investors from investing or participating in any particular enterprise whether or not such
enterprise has products or services which compete with those of the Company. 
 [Signature Pages Follow] 

  
 24 








 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	COMPANY:
	
	ZENDESK, INC.
		
	By:	 	/s/ Mikkel Svane
	Name: Mikkel Svane
	Title: Chief Executive Officer



  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
			
	INVESTORS:
	
	 Redpoint Omega II, L.P., by its General Partner Redpoint Omega II, LLC

		
	By:	 	/s/ Satish Dharmaraj
		 	Satish Dharmaraj, Managing Director
	
	 Redpoint Omega Associates II, LLC, as nominee

		
	By:	 	/s/ Satish Dharmaraj
		 	Satish Dharmaraj, Managing Director



  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
			
	INVESTORS:
	
	INDEX VENTURES GROWTH II (JERSEY), L.P
	 By: its Managing General Partner:

Index Venture Growth Associates II Limited

	
	 /s/ N. P. Ginnis

	 N.P. Ginnis
 Director 

	
	 INDEX VENTURES GROWTH II PARALLEL

ENTREPRENEUR FUND (JERSEY), L.P

	
	 By: its Managing General Partner:

Index Venture Growth Associates II Limited

	
	 /s/ N. P. Ginnis

	 N.P. Ginnis
 Director

 
 Address:
  

Index Venture Growth Associates II Limited
 No 1 Seaton Place

St Helier
 Jersey JE4 8YJ

Channel Islands
 Attention: Nicky Barthorp

Fax + 44 (0) 1534 605605




  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
			
	 INVESTORS:
  

YUCCA PARTNERS LP JERSEY BRANCH
  

By: Ogier Employee Benefit Services Limited as Authorised Signatory of Yucca Partners LP Jersey Branch in its capacity as administrator of the Index
Co-Investment Scheme,

	
	 /s/ Giles Johnstone-Scott and Alex Di Santo

	 Authorised Signatory - Ogier Employee Benefit Services Limited

 
 Address:
  

Ogier Employee Benefit Services Limited
 Ogier House

The Esplanade
 St Helier

Jersey JE4 9WG
 Channel Islands

Facsimile +44 (0) 1534 504444
 Attention: Peter
Mitchell/Shane Hugill
  
 With copies to:

Index Venture Management S.A.
 2 rue de Jargonnant

1207 Geneva
 Switzerland

Fax: +41 22 737 0099
 Attention: Andre Dubois




  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
			
	INVESTORS:
	
	 GGV Capital IV L.P.

By: GGV Capital IV L.L.C., its General Partner

		
	By:	 	 /s/ Glenn Solomon

		 	 Glenn Solomon
 Managing
Director

	
	 GGV Capital IV Entrepreneurs Fund L.P.

By: GGV Capital IV L.L.C., its General Partner

		
	By:	 	 /s/ Glenn Solomon

		 	 Glenn Solomon
 Managing
Director




  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
			
	 INVESTORS:
  

GS DIRECT, L.L.C.

		
	By:	 	/s/ Anthony Noto
		
	Name:	 	Anthony Noto
		
	Title:	 	Vice President



  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
			
	 INVESTORS:
  

MATRIX PARTNERS IX, L.P.

		
	By:	 	 Matrix IX Management Co., L.L.C.,
 its
General Partner

		
	By:	 	/s/ Dana Stalder
		
	Name:	 	Dana Stalder
		 	Managing Member


  

			
	Address:	 	 Bay Colony Corporate Center
 1000 Winter
Street, Suite 4500
 Waltham, MA 02451



  

			
	WESTON & CO. IX LLC, as Nominee
		
	By:	 	 Matrix Partners Management Services, L.P.,

Sole Member

		
	By:	 	 Matrix Partners Management Services GP, LLC,

its General Partner

		
	By:	 	/s/ Dana Stalder
		
	Name:	 	Dana Stalder
		 	Authorized Member



  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
							
	 INVESTORS:
  

CHARLES RIVER PARTNERSHIP XIII, LP

	By:	 	Charles River XIII GP, LP
		 	Its	 	General Partner
		 		 	By:	 	Charles River XIII GP, LLC
		 		 	Its:	 	General Partner


  

			
	By:	 	/s/ Devdutt Yellurkar
		 	 Authorized Manager



  

					
	CHARLES RIVER FRIENDS XIII-A, LP
	By:	 	Charles River XIII GP, LLC
		 	Its:	 	General Partner


  

			
	By:	 	/s/ Devdutt Yellurkar
		 	 Authorized Manager



  

			
	 Address:
  

Charles River Ventures
 One Broadway, 15th Floor

Cambridge, MA 02142
  

Attention: General Counsel
 Facsimile: (781) 768-6100

 
 with a copy (which shall not constitute notice) to:

 
 Sarah Reed, Esq.

Charles River Ventures, LLC
 One Broadway, 15th Floor

Cambridge, MA 02142
 Facsimile: 781-768-6230




  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
			
	 INVESTORS:
  

BENCHMARK CAPITAL PARTNERS VI, L.P.
 as nominee
for
 Benchmark Capital Partners VI, L.P.,
 Benchmark
Founders’ Fund VI, L.P.,
 Benchmark Founders’ Fund VI-B, L.P.

and related individuals
  

	By:	 	Benchmark Capital Management Co. VI,
	L.L.C., its general partner


  

			
	By:	 	/s/ Steven M. Spurlock
	Managing Member


  

			
	 Address:
  

2480 Sand Hill Road, Suite 200
 Menlo Park, CA 94025

 
 with a copy (which shall not constitute notice) to:

 
 Gunderson Dettmer Stough Villeneuve

Franklin & Hachigian, LLP
 1200 Seaport Blvd.

Redwood City, CA 94063




  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 
	
	INVESTORS:
	
	 RJ Beteiligungsgesellschaft mbH
 By: Christoph
Janz, Managing Director

	
	 /s/ Christoph Janz

	 Christoph Janz
  

Address:
  

RJ Beteiligungsgesellschaft mbH
 Albert-Schöchle-Weg 3

D-71640 Ludwigsburg Germany




  
 [Signature Page to Third
Amended and Restated Investors’ Rights Agreement] 








 SCHEDULE A 

Investors 
 Charles River Partnership XIII,
LP 
 Charles River Friends XIII-A, LP 
 Benchmark Capital
Partners VI, L.P. 
 RJ Beteiligungsgesellschaft mbH 
 Matrix
Partners IX, L.P. 
 Weston & Co. IX LLC, as Nominee 

Redpoint Omega II, L.P. 
 Redpoint Omega Associates II, LLC 

Index Ventures Growth II (Jersey), L.P 
 Index Ventures Growth II
Parallel Entrepreneur Fund (Jersey), L.P 
 Yucca Partners LP Jersey Branch 

GGV Capital IV L.P. 
 GGV Capital IV Entrepreneurs Fund L.P. 

GS Direct, L.L.C.